As one of the fastest growing fields in science, biopharmaceuticals offer exciting opportunities for researchers and businesses. To support the rapid advances being made, we have developed a wide range of services that draw on our long-standing expertise in biopharmaceutical testing, safety and quality control.
Looking for something specific?
Search within Biopharmaceutical Development and Quality Control Testing
We provide a comprehensive portfolio for analytical testing requirements during biopharmaceutical development. Our range of integrated laboratory services offers expertise for every stage – from early phase cell bank safety assessment and product characterization to later phase method development, bioanalysis and final phase product release. Our biopharmaceutical development services can help you with:
- Preparation and characterization of analytical master cell banks and working cell banks
- cGMP analytical chemistry QC release testing, with tests such as capillary electrophoresis (CE), cell based assays, ELISA based assays, oligosaccharide analysis, peptide mapping, and surface plasmon resonance (SPR)/bio-layer interferometry (BLI) analysis
- Elemental impurities testing
- Optimization, development and validation of methods
- Impurity identification
- Particle analysis
We provide a comprehensive partnership with access to technical and laboratory expertise, as well as flexible business development solutions for your own specific requirements, including:
- Up-front consultation: discuss technical and regulatory aspects of testing with our panels of experts
- Business development: elect the most appropriate working partnership, from “fee-for-service” to FTE models
To discuss your requirements and the available partnership options, contact us today.